This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Mount Sinai Medical Center 1st In Tri-State Area To Discharge Patient Without Human Heart









TUCSON, Ariz., Nov. 8, 2012 /PRNewswire/ -- SynCardia Systems, Inc. ( www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE ( Europe) approved Total Artificial Heart, announced today that The Mount Sinai Medical Center in New York City, has become the first hospital in the tri-state area to discharge a patient implanted with the SynCardia temporary Total Artificial Heart. On Oct. 25, Daquain Jenkins left the hospital to wait for a matching donor heart at home using the Freedom® portable driver to power his Total Artificial Heart.

(Photo: http://photos.prnewswire.com/prnh/20121108/LA08504)

"We believed that the SynCardia Total Artificial Heart was the only hope of saving Daquain's life, and as part of Mount Sinai's commitment to providing the best care for our patients, we made sure he got it," said Dr. Anelechi Anyanwu, Associate Professor of Cardiothoracic Surgery. "The portable driver will help him maintain his quality of life as he will be able to go home, enjoy being with his kids, and resume his activities of daily living."

Mr. Jenkins, 28, says he is grateful the Freedom portable driver will give him the opportunity to walk his kids to the bus stop; a simple task he was unable to do when his first heart transplant failed.

"Without this device, I wouldn't be here," said Mr. Jenkins. "Now, I take everything life brings me with a smile."

At age 25, Mr. Jenkins was diagnosed with congestive heart failure when he went to the doctor with symptoms of pneumonia. His father had died of heart failure at age 28. Mr. Jenkins began medical therapy, which worked for a year before he started experiencing symptoms again. He was implanted with a pacemaker and a defibrillator at a local hospital, but his condition continued to deteriorate.

When Mr. Jenkins' local cardiologist recommended he come to Mount Sinai for treatment, Dr. Ajith Nair, Assistant Professor of Medicine (Cardiology), evaluated him and recommended he undergo heart transplantation. In April 2011, he received a heart transplant at Mount Sinai, but after a year, his body rejected the donor heart.

Both sides of Mr. Jenkins' donor heart were failing rapidly. To save his life, a team was assembled and certified in two days, the SynCardia Total Artificial Heart was flown in from Arizona and on Aug. 17, doctors performed Mount Sinai's first implant during an eight-hour surgery, proctored by world-renowned heart surgeon Dr. Jack Copeland.

Weighing 13.5 pounds (~6 kg), the Freedom portable driver is the world's first wearable power supply for the SynCardia Total Artificial Heart. The Freedom portable driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.

Read press release from Mount Sinai Like SynCardia on Facebook: http://www.facebook.com/pages/SynCardia-Systems-Inc/191245900926019 Follow SynCardia on Twitter – http://twitter.com/SynCardia   Connect with SynCardia on Linked In - http://www.linkedin.com/company/syncardia-systems-inc.

CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use.

About the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. ( Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart… read more

SOURCE SynCardia Systems, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs